The 3D Cell Cultures Market will be worth US$ 2,717.6 Million at a CAGR of 29.1% from 2021. With interconnected ecosystems taking the center stage, advancements in technology are bound to bring about a digital alteration in the healthcare vertical. Also, bio-based medications are on the anvil.
According to a new market report titled “Global Market Study on 3D Cell Culture: Asia to Witness Highest Growth by 2020”, published by Persistence Market Research, the global 3D cell culture market was valued at US$ 586.1 Mn in 2014 and is expected to expand at a CAGR of 29.1% to account for US$ 2,717.6 Mn by 2020.
3D cell culture refers to a process of growing cell culture in a 3D environment. It is an advanced cell culture technique that overcomes limitations of 2D cell culture in terms of cellular characteristics and behavior. Need for developing a cell culture method which can accurately stimulate normal cell morphology, proliferation, differentiation, and migrations led to the development of 3D cell culture techniques. Effect of drug doses can be studied more effectively in 3D cell culture as compared to conventional 2D cell culture, as cells grow more realistically in the former.
Want Insights To 3D Cell Cultures Market? Ask For Sample! https://www.persistencemarketresearch.com/samples/3329
Some of the major players in the 3D cell culture market:
- Sigma-Aldrich Corporation.
- Thermo Fisher Scientific, Inc.
- Corning Incorporated.
- Becton
- Dickinson and Company.
- 3D Biotek LLC.
- Lonza Group.
- 3D Biomatrix, Inc.
- InSphero AG.
- Reinnervate Ltd.
- Global Cell Solutions, Inc.
Planning To Conclude Your Strategy On A Decisive Note In The 3D Cell Cultures Market? Glance Through The “Methodology” Implied! https://www.persistencemarketresearch.com/methodology/3329
Globally, the 3D cell culture market is witnessing significant growth due to the rising investment by major players in the market, increasing research related activities, and rising demand for organ transplantation. Moreover, 3D cell culture’s ability to replace the animal in research and pharmaceutical testing is also driving the growth of the market.
However, budgetary constraints faced by small and medium-sized laboratories and lack of consistency in 3D cell culture products restrains the growth of the 3D cell culture market. The market was valued at US$ 586.1 Mn in 2014 and expected to account for US$ 2,717.6 Mn by 2020 at a CAGR of 29.1%.
How About Knowing The Product/Technology Driving The 3D Cell Cultures Market Before Investing Therein? Click The “Purchase Now” Button Of Our 3D Cell Cultures Market Report! https://www.persistencemarketresearch.com/checkout/3329
Europe was the largest market for 3D cell culture in 2014. This is mainly due rising investments in 3D cell culture market and increasing research related activities. The Europe market for 3D cell culture was valued at US$ 234.4 Mn in 2014 and is expected to account for US$ 1,067.8 Mn by 2020 at a CAGR of 28.7%. On the basis of technology, microchips are the fastest growing segment.
On the basis of application, drug discovery is the largest segment in the 3D cell culture market. Among end users, biotechnology and biopharmaceuticals industries segment is the fastest growing segment in the 3D cell culture market.
Access Related Reports:
Neurostimulation Devices Market:
The global neurostimulation devices market was valued at US$ 5,088.9 Mn in 2014 and is expected to grow at a CAGR of 12.7% from 2014 to 2020, to reach US$ 10,445.7 Mn by 2020.
Nano Healthcare Technology for Medical Equipment Market:
According to this research report, the global market Nano healthcare technology for medical equipment is expected to expand at a robust CAGR of 9.6% during the period of forecast 2017-2022.
Sarcopenia Treatment Market:
According to the latest market report published by the company titled ‘Sarcopenia Treatment Market: Global Industry Analysis 2013 – 2017 and Forecast, 2018 – 2026,’ the global sarcopenia treatment market is projected to reach US$ 3,302.0 Mn by the end of 2026 and grow at a CAGR of 4.2% during the forecast period.
Ineffective Esophageal Motility Treatment Market:
According to the latest report published by PMR, the global ineffective esophageal motility treatment market is projected to expand at a decent CAGR of around 6% during the forecast period (2020–2030).
About Us:
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com